Zurueck zur Suche

Reporte zur Charge U016057

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 TX 2 NY 1 NJ 1

VAERS 2544590

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

kritisch
Staat
MI
Alter
82,0
Geschlecht
F
Eingang
28.12.2022
Impfdatum
29.10.2021
Beginn
22.12.2022
Tage bis Beginn
419,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Acute kidney injury Acute respiratory failure Aspiration pleural cavity Asthenia Atrial fibrillation Brain natriuretic peptide increased COVID-19 Cardiac valve disease Cardioactive drug level increased Chest X-ray abnormal Chronic left ventricular failure Condition aggravated Diuretic therapy Dyspnoea Electrocardiogram abnormal Essential hypertension Fatigue Hypotension

Symptomtext

COVID+ 12/22/22. Vaccination Status - Moderna x3 BRIEF OVERVIEW: Discharge Provider: Primary Care Provider at Discharge: Admission Date: 12/22/2022 Discharge Date: 12/27/2022 Active Hospital Problems Diagnosis Date Noted POA ? AKI (acute kidney injury) 12/24/2022 Unknown ? COVID-19 12/22/2022 Unknown ? Atrial fibrillation with RVR 12/22/2022 Unknown ? Pleural effusion, bilateral 12/22/2022 Unknown ? Chronic combined systolic and diastolic heart failure 09/28/2022 Yes ? Valvular heart disease 09/28/2022 Yes ? Paroxysmal atrial fibrillation 09/14/2022 Yes ? Primary hypertension DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pleural effusion [J90] Atrial fibrillation with RVR [I48.91] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Pt. is a 83 y.o. female who presented with shortness of breath, fatigue and weakness that started roughly 5 days ago. She denies dizziness, headache, palpitations, chest pain/pressure, fever, chills, body aches, cough, congestion, lower extremity edema. No nausea, vomiting, diarrhea, dysuria. Upon arrival to the emergency department she was found to be hypoxic with SpO2 79%, and tachypnea with RR 29. EKG was performed and demonstrated atrial fibrillation with RVR. CXR demonstrated large left pleural effusion and small right pleural effusion with vascular congestion bilaterally. BNP 10478. Troponin 21. Positive COVID nasal swab. Current vital signs 95% on 2 L nasal cannula, RR 28, blood pressure 160/122, HR 154. Patient reports that her symptoms have improved since arrival however she does state that her shortness of breath continues to be moderate in intensity. She denies pain at this time. The above vital signs, and radiographs, labs reviewed and interpreted by me on 12/22/2022. Patient was referred to admission to hospitalist service, inpatient progressive care unit. Patient was diuresed with intravenous Lasix and placed on a Cardizem drip for rate control. She underwent thoracentesis with removal of 500 mL of fluid. With these measures she was able to be weaned off oxygen but she became mildly hypotensive. Cardizem had to be discontinued. She was started on digoxin for control of her heart rate with good results; however she did have some pauses with an elevated digoxin level. Case was discussed with Cardiology to was recommended maintaining her on a beta-blocker, adding a low-dose of oral Cardizem with the patient could tolerate. Patient continue improved but she did have some nighttime hypoxemia. She was kept an additional day for a nighttime oxygen saturation study to possibly qualify her for oxygen. She did not qualify for oxygen. Labs and vitals are stable.Patient is eager to discharge, she has been discharged in a stable medical condition with her family.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Primary hypertension Mixed hyperlipidemia Tubular adenoma of colon GERD (gastroesophageal reflux disease) High cholesterol History of Barrett's esophagus Mitral stenosis Mild aortic stenosis Osteoporosis, unspecified osteoporosis type, unspecified pathological fracture presence Psoriasis Onychomycosis Paroxysmal atrial fibrillation Chronic combined systolic and diastolic heart failure Valvular heart disease
Andere Medikamente
Aspirin 81 mg Oral Daily Carvedilol 12.5 MG take 1 tablet by mouth twice a day with meals Clobetasol Propionate 0.05 % Apply externally Daily PRN, To the scalp Diclofenac Sodium 1 % Topical 2 times daily, To affected joints for pain Omepraz
Allergien
Sulfa DrugsRash
Vorherige Impfungen
-

VAERS 1952681

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

mild
Staat
TX
Alter
65,0
Geschlecht
F
Eingang
15.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Lymphadenopathy Mass Pain in extremity Peripheral swelling Rash Rash erythematous

Symptomtext

Bright red rash, swelling, and pain from elbow to top of shoulder. Lump near shoulder blade (enlarged lymph node).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Verapamil; Mirtazapine; Levothyroxine; Clopidegrel; Multi-vitamin; Vitamin D
Allergien
Codeine, x-ray dye
Vorherige Impfungen
-

VAERS 1943959

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

mild
Staat
TX
Alter
2,0
Geschlecht
F
Eingang
13.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cough Immediate post-injection reaction Vomiting

Symptomtext

coughing and vomiting immediately after vaccination. Oral benadryl and observation. Patient returned to baseline and was discharged home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hearing loss
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1850482

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

mild
Staat
NY
Alter
46,0
Geschlecht
F
Eingang
08.11.2021
Impfdatum
16.09.2021
Beginn
17.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electromyogram Injection site pain

Symptomtext

Developed pain after injection. On 9/30 and 10/26 saw her primary with ongoing complaints of pain at the injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
EMG
Aktuelle Erkrankungen
none
Vorgeschichte
Asthma
Andere Medikamente
albuterol
Allergien
none
Vorherige Impfungen
-

VAERS 1723048

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

mild
Staat
MI
Alter
82,0
Geschlecht
M
Eingang
22.09.2021
Impfdatum
20.09.2021
Beginn
21.09.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Patient reported to the office on 09/22/21 with redness to right upper arm that started at bottom injection site. redness extended about 6 inches from injections site and wrapped around arm about 7 inches not touching under the arm the area is swollen and warm to touch. there was pain per the patient on 09/21/21. no pain in elbow, or shoulder or neck. pt is being treated for cellulitis with antibiotic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Mandibular hypoplasia Arthritis Dyslipidemia CPAP (continuous positive airway pressure) dependence OSA (obstructive sleep apnea) Bladder stone Osteoarthritis of left hip, unspecified osteoarthritis type Osteoarthritis of left hip Prostate cancer (HCC) Primary osteoarthritis of left knee Aortic valve stenosis, etiology of cardiac valve disease unspecified Chronic diastolic heart failure, NYHA II Severe aortic stenosis CAD (coronary artery disease)
Andere Medikamente
aspirin 81 MG enteric coated tablet Take 81 mg by mouth daily. atorvastatin (LIPITOR) 40 MG tablet Take 40 mg by mouth nightly. clopidogrel (PLAVIX) 75 MG tablet Take 1 tablet by mouth daily. doxycycline (VIBRA-TABS) 100 MG tablet Take 1 ta
Allergien
PENICILLINS Noted Status Severity Type Reaction 06/19/18 0903 , RN 06/24/13 Active High Allergy Rash Comments: MORE THAN 10 YEARS AGO COFFEE Noted Status Severity Type Reaction 06/19/18 0903 RN 06/24/13 Active High Allergy Hives CODEINE Noted Status Severity Type Reaction 06/19/18 0902 RN 02/18/14 Active Medium Intolerance Other, Dizziness Comments: INCOHERENT
Vorherige Impfungen
-

VAERS 1727502

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U016057

gering
Staat
NJ
Alter
66,0
Geschlecht
F
Eingang
23.09.2021
Impfdatum
16.09.2021
Beginn
17.09.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cellulitis Erythema Peripheral swelling Skin warm

Symptomtext

Very red and swollen arm warm to the touch with redness extending down to elbow. Cellulitis diagnosed in Emergency Room. Keflex 500 mg given 4 x day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cellulitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Obesity, heart disease, hyperlipidemia.
Andere Medikamente
Fish oil, aspirin 81 mg, Centrum Silver, Zetia 10 mg., lutein/zeaxanthin, losartan 25 mg, Lipitor 40 mg.
Allergien
None
Vorherige Impfungen
-